Study title and authors:
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Ann W. Hsing, Streamson Chua Jr, Yu-Tang Gao, Elisabeth Gentzschein, Lilly Chang, Jie Deng and Frank Z. Stanczyk
Affiliations of authors: A. W. Hsing, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; S. Chua, Jr., Division of Molecular Genetics, Department of Pediatrics, Columbia University, New York, NY; Y.-T. Gao, J. Deng, Shanghai Cancer Institute, China; E. Gentzschein, L. Chang, F. Z. Stanczyk, Department of Obstetrics and Gynecology and Preventive Medicine, School of Medicine, University of Southern California, Los Angeles.
This paper can be accessed at: http://jnci.oxfordjournals.org/content/93/10/783.short
The study investigated if insulin is associated with prostate cancer risk. Blood samples were collected from 128 patients with prostate cancer and from 306 healthy control subjects.
Hsing found that men with the highest insulin levels had a 2.56-fold increased risk of prostate cancer compared with men with the lowest insulin levels.
High insulin levels are caused by diets high in carbohydrates
AMAZON UK Carbohydrates Can Kill
AMAZON USA Carbohydrates Can Kill